Pulmonary hypertension laboratory tests

Revision as of 17:51, 25 September 2012 by Shankar Kumar (talk | contribs)
Jump to navigation Jump to search

Pulmonary Hypertension Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pulmonary hypertension from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History & Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pulmonary hypertension laboratory tests On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Google Images

American Roentgen Ray Society Images of Pulmonary hypertension laboratory tests

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulmonary hypertension laboratory tests

CDC on Pulmonary hypertension laboratory tests

Pulmonary hypertension laboratory tests in the news

Blogs on Pulmonary hypertension laboratory tests

Directions to Hospitals Treating Pulmonary hypertension

Risk calculators and risk factors for Pulmonary hypertension laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Assistant Editor(s)-in-Chief: Ralph Matar,

Overview

Laboratory Findings

Systemic sclerosis is very important to exclude in pulmonary hypertension because this systemic disease has a very high prevalence of pulmonary arterial hypertension. Anti-Scl-70, anti-centromere, and U3-RNP are typically positive.

References

Template:WikiDoc Sources